Targeted Therapeutics for Parkinson’s and related disorders: Hopes and Challenges

Dates and Times

Start: 12/6/2024 8:00 AM
End: 12/6/2024 9:00 AM

Objectives

• To understand the diagnostic and therapeutic challenges of heterogeneity in neurodegenerative movement disorders.
• To understand how these challenges can motivate the basic and clinical research priorities in an academic movement disorders division and through academic-industry collaborations.
• To contextualize recent drug-discovery efforts that led to stearoyl-coA desaturase inhibitors as a potential lipid-directed therapeutic for amelioration of Parkinson’s disease progression.

Speakers

Accreditation

The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits ^™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.